Red blood cell lifespan, erythropoiesis and hemoglobin control

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 247-254

  Kruse, A ^a   Uehlinger, D ^b,c   Gotch, F ^a   Kotanko, P ^a   Levin, N ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ALGORITHM; BLOOD; CELL SURVIVAL; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; KIDNEY FAILURE; PHYSIOLOGY; REVIEW;

ALGORITHMS; CELL SURVIVAL; ERYTHROCYTES; ERYTHROPOIESIS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE;

EID: 48049090743     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000130698     Document Type: Conference Paper

References (15)

1. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, et al: Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998;80:173-195.
2. Arese P, Turrini F, Schwarzer E: Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-146.
3. Kuypers FA, de Jong K: The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-Grand) 2004;50:147-158.
4. Sambrano GR, Parthasarathy S, Steinberg D: Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1994;91:3265-3269.
5. Bonomini M, Sirolli V: Uremic toxicity and anemia. J Nephrol 2003;16:21-28.
6. Sirolli V, Cappelli P, Amoroso L, Di Liberato L, Muscianese P, Santarelli P, et al: Online HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane (in Italian). G Ital Nefrol 2004;21(suppl 30):S208-S211.
7. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, et al: Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-2757.
8. Polenakovic M, Sikole A: Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol 1996;7:1178-1182.
9. Weinstein T, Chagnac A, Korzets A, Boaz M, Ori Y, Herman M, et al: Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant 2000;15:883-887.
10. Usberti M, Gerardi G, Micheli A, Tira P, Bufano G, Gaggia P, et al: Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol 2002;15:558-564.
11. Stenvinkel P: The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001;16(suppl 7):36-40.
12. Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD: Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 2006;81:432-438.
13. Uehlinger DE, Gotch FA, Sheiner LB: A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin Pharmacol Ther 1992;51:76-89.
14. Krzyzanski W, Perez-Ruixo JJ: An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects. Pharm Res 2007;24:758-772.
15. Strocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD: A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-399.